Selzentry News
Most Popular Selzentry Story
Selzentry - 2007 FDA approvals
Drug: Selzentry (maraviroc) Indication: HIV Company: Pfizer Approval Date: August 6, 2007 Scoop: Selzentry is a CCR5 antagonist, which prevents the virus from entering white blood cells. The process... Read more...
Latest Headlines
- January 30, 2008
- January 9, 2008
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
